Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

XSpray Pharma AB (publ)

Closing information (x1000 SEK)

Closing information 2023/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 675 Less Arrow 4 More Arrow 6
Earnings before taxes -179,684 More Arrow -96,698 More Arrow -52,410
EBITDA -181,734 More Arrow -97,953 More Arrow -53,457
Total assets 765,263 Less Arrow 622,903 Less Arrow 605,303
Current assets 217,815 More Arrow 282,065 More Arrow 331,015
Current liabilities 39,903 Less Arrow 29,966 Less Arrow 19,818
Equity capital 693,413 Less Arrow 591,752 Less Arrow 582,587
- share capital 31,254 Less Arrow 20,680 Less Arrow 18,893
Employees (average) 26 Less Arrow 22 Less Arrow 20

Financial ratios

Fiscal year 2023/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency 90.6% More Arrow 95.0% More Arrow 96.2%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -23.4% More Arrow -15.5% More Arrow -8.7%
Current ratio 545.9% More Arrow 941.3% More Arrow 1670.3%
Return on equity (ROE) -25.9% More Arrow -16.3% More Arrow -9.0%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 4 Less Arrow 2 More Arrow 3
Chg. No. of employees % 18% Less Arrow 10% More Arrow 18%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.